Stanford Medicine researchers have developed a new method for influenza vaccination that encourages a robust immune response to all four common flu subtypes, potentially increasing the vaccine’s efficacy.
In laboratory tests using human tonsil organoids, the modified vaccine showed promising results in combating both seasonal and bird flu strains. The approach involves a combined antigen methodology that might also protect against emerging flu variants with pandemic potential.
Innovative Flu Vaccine Development
Leave a reply